Your browser doesn't support javascript.
loading
A population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIV.
Bukkems, Vera E; Post, Teun M; Colbers, Angela P; Burger, David M; Svensson, Elin M.
Afiliación
  • Bukkems VE; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Post TM; Leiden Experts on Advanced Pharmacokinetics and Pharmacodynamics (LAP&P), Leiden, The Netherlands.
  • Colbers AP; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Svensson EM; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
CPT Pharmacometrics Syst Pharmacol ; 10(2): 161-172, 2021 02.
Article en En | MEDLINE | ID: mdl-33369217
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Transmisión Vertical de Enfermedad Infecciosa / Fármacos Anti-VIH / Raltegravir Potásico Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Transmisión Vertical de Enfermedad Infecciosa / Fármacos Anti-VIH / Raltegravir Potásico Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article